Articles citing this paper
Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females
Asvini K. Subasinghe
A B H I , John D. Wark C D , Samuel Phillips A B , Alyssa Cornall A B E , Julia M. L. Brotherton F G and Suzanne M. Garland A B E
A Centre for Women’s Infectious Diseases Research, Royal Women’s Hospital, 20 Flemington Road, Parkville, Vic. 3052, Australia.
B Murdoch Children’s Research Institute, Infection and Immunity, Royal Women’s Hospital, Flemington Road, Parkville, Vic. 3052, Australia.
C The University of Melbourne Department of Medicine, Royal Melbourne Hospital, Parkville, Vic. 3050, Australia.
D Bone and Mineral Medicine, Royal Melbourne Hospital, Parkville, Vic. 3050, Australia.
E Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, Vic. 3052, Australia.
F VCS Population Health, VCS Foundation, East Melbourne, Vic. 3002, Australia.
G Melbourne School of Population and Global Health, The University of Melbourne, Vic. 3053, Australia.
H Present address: Department of General Practice, Monash University, 1/270 Ferntree Gully Road, Notting Hill, Vic. 3168, Australia.
I Corresponding author. Email: asvini.subasinghe@monash.edu
Sexual Health 17(6) 510-516 https://doi.org/10.1071/SH20033
Submitted: 11 March 2020 Accepted: 26 October 2020 Published: 21 December 2020
